Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Boxer Capital Management, LLC
Form 13F · Q2 2026

Boxer Capital Management, LLC

CIK 2018299Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.3B
Reported book value
63
Positions
7
Quarters on record
Top 50
Positions

Boxer Capital Management, LLC — holdings

Top 50 positions of 63, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TNGX Tango Therapeutics Inc10.9M+0.0%$340M25.6%
2RVMD Revolution Medicines Inc500,000+0.0%$94M7.1%
3ABIVAX SA Abivax Sa605,000+202.5%$81M6.1%
4UNIQURE NV Uniqure Nv1.5M+127.1%$69M5.2%
5KOD Kodiak Sciences Inc1.5M+8.6%$58M4.3%
6KYMR Kymera Therapeutics Inc429,100+30.4%$49M3.7%
7DFTX Definium Therapeutics Inc998,500+66.8%$47M3.5%
8REPL Replimune Group Inc4.0M+239.0%$44M3.3%
9CELC Celcuity Inc416,530+85.1%$44M3.3%
10QTTB Q32 Bio Inc3.1M—$40M3.0%
11CAPR Capricor Therapeutics Inc1.4M+136.5%$34M2.5%
12PGEN Precigen Inc5.2M+47.1%$29M2.2%
13CORT Corcept Therapeutics Inc335,500+34.2%$29M2.2%
14SRZN Surrozen Inc1.1M+44.3%$27M2.0%
15PTGX Protagonist Therapeutics Inc170,000+0.0%$21M1.6%
16VIR Vir Biotechnology Inc1.9M+0.0%$19M1.4%
17PCVX Vaxcyte Inc325,000+0.0%$19M1.4%
18URGN Urogen Pharma Ltd500,000+0.0%$18M1.4%
19CRVS Corvus Pharmaceuticals Inc1.1M+0.0%$16M1.2%
20PTCT Ptc Therapeutics Inc200,000+0.0%$16M1.2%
21PRAX Praxis Precision Medicines I46,457+0.0%$16M1.2%
22AMLX Amylyx Pharmaceuticals Inc800,000+0.0%$14M1.1%
23OCUL Ocular Therapeutix Inc1.3M+271.4%$13M1.0%
24IRD Opus Genetics Inc2.8M+25.1%$12M0.9%
25PALI Palisade Bio Inc4.8M+0.0%$10M0.8%
26APOGEE THERAPEUTICS INC Apogee Therapeutics Inc70,000+0.0%$9M0.7%
27SYRE Spyre Therapeutics Inc100,000—$9M0.7%
28COGT Cogent Biosciences Inc225,000+0.0%$9M0.7%
29CYTK Cytokinetics Inc100,000+0.0%$9M0.6%
30RLAY Relay Therapeutics Inc450,000—$8M0.6%
31CBIO Crescent Biopharma Inc.453,686+0.0%$8M0.6%
32CTNM Contineum Therapeutics Inc494,000+0.0%$8M0.6%
33KZIA Kazia Therapeutics Ltd560,000—$8M0.6%
34STTK Shattuck Labs Inc1.0M—$7M0.5%
35AVTX Avalo Therapeutics Inc375,000+25.0%$7M0.5%
36FORTE BIOSCIENCES INC Forte Biosciences Inc274,500—$6M0.4%
37RLMD Relmada Therapeutics Inc842,106+0.0%$6M0.4%
38MLTX Moonlake Immunotherapeutics275,000+0.0%$5M0.4%
39ZURA Zura Bio Ltd900,000+0.0%$5M0.4%
40CYBIN INC Cybin Inc790,000+23.4%$5M0.4%
41ODTX Odyssey Therapeutics Inc275,000—$5M0.4%
42IMTX Immatics N.V475,000—$5M0.4%
43FTH Faeth Therapeutics Inc180,505—$5M0.3%
44GPCR Structure Therapeutics Inc75,000+0.0%$4M0.3%
45ORIC Oric Pharmaceuticals Inc350,000+98.3%$4M0.3%
46ANTX An2 Therapeutics Inc749,035+0.0%$4M0.3%
47NMRA Neumora Therapeutics Inc.2.0M—$3M0.3%
48INO Inovio Pharmaceuticals Inc2.8M+20.0%$3M0.2%
49ALLO Allogene Therapeutics Inc1.5M−45.0%$3M0.2%
50SLDB Solid Biosciences Inc300,000+0.0%$3M0.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.